Skip to main content
. 2022 Dec 21;9:928974. doi: 10.3389/fcvm.2022.928974

Figure 2.

Figure 2

Arrhythmia-free survival in patients with previous mitral valve (MV) surgery patients vs. control at the end of follow-up after a median of 2 (2–2) catheter ablation. The proportion of patients off antiarrhythmic drugs is specified for each group. The number of patients at risk at each time interval is shown below the figure. The p-value reflects the Log-rank significance at the end of the follow-up.